TITLE

Thromboprophylaxis in Patients with Acute Spinal Injuries: An Evidence-Based Analysis

AUTHOR(S)
Ploumis, A.; Ponnappan, R. K.; Maltenfort, M. G.; Patel, R. X.; Bessey, J. T.; Albert, T. J.; Harrop, J. S.; Fisher, C. G.; Bono, C. M.; Vaccaro, A. R.
PUB. DATE
November 2009
SOURCE
Journal of Bone & Joint Surgery, American Volume;Nov2009, Vol. 91-A Issue 11, p2568
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The increased risk for venous thromboembolic events following spinal trauma is well established. The purpose of the present study was to examine the literature in order to determine the optimum thromboprophylaxis regimen for patients with acute spinal injuries with or without spinal cord injury. Methods: EMBASE, MEDLINE, and Cochrane databases were searched from the earliest available date to April 2008 for clinical trials comparing different methods of thromboprophylaxis in adult patients following acute spinal injuries (with or without spinal cord injury). Outcome measures included the prevalences of deep-vein thrombosis and pulmonary embolism and treatment-related adverse events. Results: The search yielded 489 studies, but only twenty-one of them fulfilled the inclusion criteria. The prevalence of deep-vein thrombosis was significantly lower in patients without spinal cord injury as compared with patients with spinal cord injury (odds ratio = 6.0; 95% confidence interval = 2.9 to 12.7). Patients with an acute spinal cord injury who were receiving oral anticoagulants had significantly fewer episodes of pulmonary embolism (odds ratio = 0.1; 95% confidence interval = 0.01 to 0.63) than those who were not receiving oral anticoagulants (either untreated controls or patients managed with low-molecular-weight heparin). The start of thromboprophylaxis within the first two weeks after the injury resulted in significantly fewer deep-vein-thrombosis events than delayed initiation did (odds ratio = 0.2; 95% confidence interval = 0.1 to 0.4). With regard to heparin-based pharmacoprophylaxis in patients with spinal trauma, low- molecular-weight heparin significantly reduced the rates of deep-vein thrombosis and bleeding episodes in comparison with the findings in patients who received unfractionated heparin, with odds ratios of 2.6 (95% confidence interval = 1.2 to 5.6) and 7.5 (95% confidence interval = 1.0 to 58.4) for deep-vein thrombosis and bleeding, respectively. Conclusions: The prevalence of deep-vein thrombosis following a spine injury is higher among patients who have a spinal cord injury than among those who do not have a spinal cord injury. Therefore, thromboprophylaxis in these patients should start as early as possible once it is deemed safe in terms of potential bleeding complications. Within this population, low-molecular-weight heparin is more effective for the prevention of deep-vein thrombosis, with fewer bleeding complications, than unfractionated heparin is. The use of vitamin K antagonists appeared to be effective for the prevention of pulmonary embolism. Level of Evidence: Therapeutic Level III. See Instructions to Authors for a complete description of levels of evidence.
ACCESSION #
45351652

 

Related Articles

  • Thoracolumbar spine trauma: Evaluation and surgical decision-making. Joaquim, Andrei F.; Patel, Alpesh A. // Journal of Craniovertebral Junction & Spine;Jan-Jun2013, Vol. 4 Issue 1, p3 

    Introduction: Thoracolumbar spine trauma is the most common site of spinal cord injury, with clinical and epidemiological importance. Materials and Methods: We performed a comprehensive literature review on the management and treatment of TLST. Results: Currently, computed tomography is...

  • High Content Screening of Neurons.  // Labmate UK & Ireland;2011, Vol. 36 Issue 3, p18 

    The article provides information on high-content screening (HCS) of neurons for spinal cord injury research.

  • Less oxygen gives more movement. Botelho, Alyssa // New Scientist;12/72013, Vol. 220 Issue 2946, p18 

    The article focuses on a research conducted by a team led by Randy Trumbower at Emory University in Atlanta, Georgia, who conducted a research among 19 volunteers suffering from spinal cord injuries and found that low oxygen can help in treatment of such injuries.

  • WEBWISE. Birkinshaw, Ian // Nursing Standard;11/26/2008, Vol. 23 Issue 12, p30 

    The article reviews the Web site Spinal Research, the leading charity for research on spinal cord injury in Great Britain.

  • Caution urged in trial of stem cells to treat spinal-cord injury. Barde, Yves // Nature;3/5/2009, Vol. 458 Issue 7234, p29 

    A letter to the editor is presented in response to the article “Stem Cells Ready for Prime Time,” in 2009 issue.

  • Discrepancies in nutritional recommendations: the need for evidence based nutrition. Mann, Jim // Asia Pacific Journal of Clinical Nutrition;Dec2002 Supplement, Vol. 11, pS510 

    The widespread acceptance that �evidence-based medicine� should determine all aspects of clinical practice leads to a consideration as to whether �evidence-based nutrition� should be based on similar principles. Randomised controlled trials (RCT) are universally regarded as...

  • Clinical Trial Registration in the Eastern Mediterranean Region.  // Oman Medical Journal;Jan2014, Vol. 29 Issue 1, p1 

    The author discusses the status of clinical trial registration in the eastern Mediterranean region. He explains the purpose and function of the World International Clinical Trial Registry Platform (ICTRP) which was established in 2006. He also suggests that clinical trial registry enables free...

  • EBM, CPGs, and OKO. Shea, Kevin G. // AAOS Now;Mar2011, Vol. 5 Issue 3, p39 

    The article focuses on the development of the clinical practice guidelines (CPGs), which is resulted from the emphasis of clinicians on evidence-based medicine (EBM). It says that CPG is developed to formulate a transparent and systematic evaluation of the clinical evidence. Moreover, the...

  • Treating venous thromboembolism with rivaroxaban.  // OB/GYN Clinical Alert;Mar2011 Clinical Briefs in Primary, p6 

    The article offers information on the result of a clinical trial which shows that rivaroxaban is effective in treating venous thromboembolism.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics